Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
ViroMissile, Inc.
Children's Oncology Group
St. Jude Children's Research Hospital
University of Nebraska
Cancer Research UK
Travera Inc
University Health Network, Toronto